SCHEMBL18609409

SCHEMBL18609409

COC(=O)c1cccc(COc2ccccc2CNC(=O)Nc2cc(OC(F)(F)F)ccc2OC)c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 7/20 0.56
L3MBTL1 Q9Y468 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.44
ALDH1A1 P00352 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
RAB9A P51151 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
NPC1 O15118 2/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
NTRK1 P04629 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18609412 0.94 MRGPRX4 (0.52) MRGPRX4L3MBTL1SMN1; SMN2ALDH1A1TDP1
SCHEMBL18609408 0.91 L3MBTL1 (0.52) MRGPRX4L3MBTL1SMN1; SMN2ALDH1A1TDP1
SCHEMBL18609825 0.87 RXRA (0.53) L3MBTL1SMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL18609826 0.86 HDAC1 (0.56) L3MBTL1SMN1; SMN2ALDH1A1TDP1RAB9A
SCHEMBL18609585 0.86 ALDH1A1 (0.49) L3MBTL1SMN1; SMN2ALDH1A1TDP1KMT2A
SCHEMBL18609595 0.86 L3MBTL1 (0.49) L3MBTL1SMN1; SMN2ALDH1A1TDP1RAB9A
SCHEMBL18609587 0.86 NAMPT (0.49) L3MBTL1SMN1; SMN2ALDH1A1KMT2ATSHR
SCHEMBL18609828 0.85 L3MBTL1 (0.48) L3MBTL1SMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL18609417 0.84 L3MBTL1 (0.50) L3MBTL1SMN1; SMN2ALDH1A1TDP1MEN1
SCHEMBL18609677 0.84 ANO1 (0.46) L3MBTL1SMN1; SMN2ALDH1A1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190010117-A1 UREA DERIVATIVE AND USE THEREFOR TORAY INDUSTRIES, INC. (JP) 2019-01-10 US disclosed
EP-3345892-A1 UREA DERIVATIVE AND USE THEREFOR Toray Industries, Inc. (JP) 2018-07-11 EP disclosed
EP-3345892-A1 UREA DERIVATIVE AND USE THEREFOR Toray Industries, Inc. (JP) 2018-07-11 EP disclosed
WO-2017038871-A1 UREA DERIVATIVE AND USE THEREFOR 東レ株式会社 2017-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190010117-A1 UREA DERIVATIVE AND USE THEREFOR UTS2R, SLC14A1, TMEM164 MRGPRX4 2181/4885L3MBTL1 3000/4885SMN1; SMN2 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.